#03 Carolina Oliveira, the founder & CEO of OneSkin Technologies | Skin Aging, OneSkin, and Building a Longevity Company
Live Longer World
00:00
C Elegans - Is This a Human Trial?
So far, you have seen promising results in terms of longevity pathways being activated. And I think one of your studies in which you did in C elegans granted is not humans, but sure that there was also an increase in median lifespan by 14%, and some health span markers also increase. So, maybe why don't you talk a bit about that? And I also believe you started a human clinical trial, so I'm not sure if you have any results from that that you can share. Yeah, no, I'm very curious to see the results when you get done.
Transcript
Play full episode
